Optometry practices typically sell for 3x–5.5x EBITDA depending on patient panel strength, payer mix, and owner dependence. Here is how buyers and sellers determine fair market value in today's eye care M&A market.
Find Optometry Practice Businesses For SaleOptometry practices in the lower middle market are primarily valued on a multiple of adjusted EBITDA, with deal prices typically ranging from 3x to 5.5x trailing twelve-month EBITDA. Valuation is heavily influenced by the size and loyalty of the active patient base, revenue diversification between insurance and optical retail, and the degree to which the practice can operate independently of the selling optometrist. Practices with strong recall systems, modern diagnostic equipment, and associate optometrists on staff consistently command multiples at the higher end of the range, while owner-dependent solo practices with declining patient volume trade at meaningful discounts.
3×
Low EBITDA Multiple
4.25×
Mid EBITDA Multiple
5.5×
High EBITDA Multiple
Solo optometry practices with heavy owner dependence, aging equipment, or a narrow payer mix concentrated in a single managed vision care plan such as VSP or EyeMed typically trade at 3x–3.5x EBITDA. Mid-range multiples of 3.75x–4.75x apply to practices with 2,000–4,000 active patients, diversified insurance and private pay revenue, and at least one associate optometrist providing clinical continuity. Premium multiples of 5x–5.5x are reserved for practices with $2M+ revenue, strong optical retail dispensary margins, documented systems enabling scalability, and modern technology including OCT and digital refraction — assets that are especially attractive to PE-backed vision care consolidators.
$1,800,000
Revenue
$450,000
EBITDA
4.5x
Multiple
$2,025,000
Price
Asset purchase with SBA 7(a) loan financing $1,620,000 (80%), buyer equity injection of $202,500 (10%), and seller note of $202,500 (10%) carried over 3 years at 6% interest. Seller agrees to a 24-month transition employment agreement at $120,000 per year to ensure patient continuity and insurance contract re-credentialing. Deal excludes accounts receivable, which seller retains, and includes all diagnostic equipment, optical inventory, patient records, and lease assignment to buyer.
EBITDA Multiple
The most widely used valuation method for optometry practices. The buyer and seller agree on a normalized EBITDA figure — adjusted for owner compensation, personal expenses, and one-time items — and apply a market multiple typically ranging from 3x to 5.5x. Add-backs commonly include above-market owner salary, personal vehicle expenses, and non-recurring equipment repairs. This method is preferred by SBA lenders and PE acquirers alike because it captures true operating cash flow available to service acquisition debt.
Best for: Practices with $800K–$4M in revenue and at least 2–3 years of consistent EBITDA margins between 20–35%; required for SBA 7(a) loan underwriting
Revenue Multiple
Some buyers and brokers apply a revenue multiple as a secondary valuation check, particularly for smaller practices where EBITDA margins are compressed or financial records are inconsistent. Optometry practices generally trade at 0.6x–1.2x annual revenue. Higher revenue multiples are associated with practices that carry strong optical retail revenue, which generates margins significantly above pure exam-based income. This method is less precise but useful for quickly benchmarking a practice against comparable sales.
Best for: Solo practices under $1M in revenue or practices with inconsistent profitability where EBITDA multiples alone may distort value
Discounted Cash Flow (DCF)
A DCF analysis projects the practice's future free cash flows over a 5–10 year horizon and discounts them back to present value using a risk-adjusted discount rate, typically 15–25% for a small healthcare practice. This method is more common in PE-backed platform acquisitions where the acquirer models post-integration synergies, geographic expansion, and optical retail growth. DCF is rarely used as the primary method in standalone lower middle market transactions but may be used to validate an EBITDA multiple offer.
Best for: PE-backed vision care consolidators and ophthalmology groups evaluating multi-location acquisitions or practices with significant near-term growth potential
Asset-Based Valuation
An asset-based approach values the practice by summing the fair market value of tangible assets — diagnostic equipment such as OCT units, slit lamps, autorefractors, optical inventory, and leasehold improvements — minus liabilities. This method typically produces the lowest valuation and is generally used only when a practice has minimal goodwill, a declining patient base, or is being acquired primarily for its equipment and real estate. It serves as a useful floor valuation in distressed situations.
Best for: Distressed practices with significant patient attrition, practices where the selling optometrist is unwilling to provide any transition support, or asset-only acquisitions where the buyer intends to rebrand entirely
Large, Loyal Active Patient Base with Strong Recall Systems
A practice with 2,500 or more active patients — defined as those seen within the past 24 months — and a documented recall program achieving 70%+ return rates signals recurring, predictable revenue that buyers pay a premium for. Automated recall systems, patient satisfaction data, and low attrition rates between exam cycles are tangible proof that the patient base will survive ownership transition.
Diversified Revenue from Optical Retail Dispensary
Practices with an attached optical dispensary generating 30–45% of total revenue from frame and lens sales command higher multiples because optical retail carries gross margins of 50–70%, far exceeding exam reimbursements from managed vision care plans. Buyers recognize that optical revenue is largely discretionary, repeatable, and less susceptible to insurance rate compression than clinical exam fees.
Modern Diagnostic Technology
Practices equipped with optical coherence tomography (OCT), digital refraction systems, visual field analyzers, and fundus photography are more attractive to buyers because they reduce near-term capital expenditure risk and signal clinical quality that supports patient retention. Practices offering telemedicine capabilities or dry eye treatment technology represent additional differentiation that supports premium pricing.
Associate Optometrists Providing Clinical Continuity
The single greatest valuation risk in an optometry acquisition is the departure of the selling OD taking patients with them. Practices where one or more associate optometrists already deliver a significant share of patient care demonstrate that the practice is not entirely dependent on the seller, substantially reducing transition risk and supporting higher EBITDA multiples.
Diversified Payer Mix with Private Pay Component
Practices that balance insurance reimbursement from VSP, EyeMed, Medicaid, and Medicare with a meaningful share of private pay patients — including uninsured exams, premium lens upgrades, and specialty contact lens fittings — are more resilient to managed care rate pressure and more attractive to acquirers evaluating long-term margin sustainability.
Favorable Long-Term Lease in a High-Traffic Location
A practice located in a high-visibility, accessible location with a lease that has at least 5–7 years of remaining term or renewal options provides buyers with confidence in location continuity. Landlord willingness to assign the lease or execute a new lease with the buyer is a prerequisite for most SBA-financed acquisitions and PE roll-ups.
Heavy Owner Dependence with No Associate Coverage
When all patient relationships, insurance credentialing, and clinical care flow through the selling optometrist alone, buyers face acute patient attrition risk at the moment of transition. This is the most cited reason for valuation discounts and deal failures in optometry acquisitions. A solo OD with no associate and a patient base that has never seen another provider may trade at 3x EBITDA or less, regardless of revenue size.
Declining Revenue or Patient Volume Over 2–3 Years
Consistent year-over-year declines in exam volume, active patient count, or optical sales without a credible explanation — such as a temporary location disruption or pandemic impact — signal structural deterioration that buyers will price aggressively into their offers or use to exit negotiations entirely. Buyers and SBA lenders both require trailing revenue to be stable or growing.
Aging or Obsolete Diagnostic Equipment
Fully depreciated equipment with no remaining useful life — slit lamps, autorefractors, or OCT units purchased more than 10–12 years ago — represents an immediate capital expenditure burden for the buyer that will be subtracted dollar-for-dollar from the purchase price in most negotiations. Sellers who ignore deferred equipment investment underestimate how significantly it suppresses valuation.
Narrow Payer Mix Dominated by a Single Plan
A practice where 60% or more of exam revenue flows through a single managed vision care plan — particularly plans with historically aggressive rate compression like Medicaid managed care — creates concentration risk that buyers will heavily discount. Loss or renegotiation of that single contract could materially impair EBITDA within months of acquisition closing.
Poor Financial Record-Keeping and Undocumented Add-Backs
Commingled personal and business expenses, inconsistent owner compensation documentation, cash transactions outside the billing system, and undocumented add-backs in EBITDA presentations create immediate red flags for buyers and SBA lenders. Without clean, reviewed financial statements for at least three years, buyers will apply larger valuation discounts to account for financial uncertainty and lenders may decline to finance the deal.
Corporate Practice of Medicine Compliance Exposure
Many states prohibit non-optometrist entities from owning or controlling optometry practices, creating structural complexity in acquisitions by PE-backed platforms or ophthalmology groups. Practices that have not proactively structured their ownership and employment arrangements in compliance with state optometry board regulations face significant legal liability that buyers will require to be resolved — often at the seller's expense — before closing.
Find Optometry Practice Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most independent optometry practices in the lower middle market sell for 3x–5.5x adjusted EBITDA. A solo practice with strong owner dependence and no associate OD will typically land in the 3x–3.75x range. A well-documented practice with 2,500+ active patients, an optical dispensary, and at least one associate providing clinical continuity can achieve 4.5x–5.5x, particularly if a PE-backed vision care consolidator is among the interested buyers. The single most impactful lever you can pull to increase your multiple is reducing owner dependence before going to market.
Buyers evaluate the patient base by analyzing active patient count — typically defined as patients seen within the past 24 months — recall program return rates, patient demographics, and exam volume trends. A practice with 2,000+ active patients and a 70%+ recall return rate is considered healthy. Buyers will request a patient aging report from the practice management system to verify these figures independently. Practices that cannot produce this data from their software are at an immediate disadvantage in negotiations because buyers will assume the worst.
Yes. Optometry practices are among the most SBA-financeable healthcare businesses because they generate predictable cash flow from recurring exam cycles and have strong historical performance data. SBA 7(a) loans can finance up to 80–90% of the purchase price, with the buyer providing a 10–20% equity injection. Many deals also include a seller note of 10–15% that satisfies part of the equity requirement. SBA lenders will require three years of practice tax returns, a detailed equipment list, proof of insurance contract transferability, and a business plan demonstrating the buyer's ability to service debt from practice cash flow.
Insurance contracts with plans like VSP, EyeMed, Medicaid, and Medicare do not automatically transfer to the buyer. The new owner must apply for re-credentialing with each payer, a process that can take 60–180 days depending on the plan and state. During this gap, the practice may need to bill under the selling OD's credentials pursuant to a transition services arrangement, which requires careful legal structuring. Buyers should begin the credentialing process immediately after signing a letter of intent, and sellers should disclose all payer contracts with current reimbursement rates during due diligence.
From the decision to sell through closing, most optometry practice sales take 12–18 months. The process includes 2–4 months of preparation — cleaning up financials, assembling due diligence documents, and engaging a broker or advisor — followed by 3–6 months of marketing and buyer identification, 2–4 months of due diligence and SBA loan processing, and 1–2 months for legal document negotiation and closing. Sellers who begin exit planning 2–3 years before their target retirement date are in the strongest position because they have time to address value killers like owner dependence, equipment upgrades, and financial record cleanup before going to market.
Goodwill in an optometry practice — the value attributed to patient relationships, brand reputation, and practice systems above and beyond tangible assets — typically represents 60–80% of the total purchase price in a healthy practice. For tax purposes, both the buyer and seller must agree on how the purchase price is allocated across asset classes using IRS Form 8594. Sellers prefer to allocate more value to personal goodwill, which may be taxed at long-term capital gains rates rather than ordinary income rates, while buyers prefer allocation to depreciable assets for faster tax write-offs. Engaging a CPA experienced in medical practice transactions before negotiating the purchase price allocation can save the seller hundreds of thousands of dollars in taxes.
More Optometry Practice Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers